Literature DB >> 15893186

Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.

Grace Lin1, Rick A Nishimura, Heidi M Connolly, Joseph A Dearani, Thoralf M Sundt, David L Hayes.   

Abstract

OBJECTIVES: We report a series of patients with severe tricuspid valve regurgitation due to a permanent pacemaker (PPM) or implantable cardioverter-defibrillator (ICD) lead.
BACKGROUND: Severe tricuspid regurgitation caused by a PPM or ICD lead is an under-recognized but treatable etiology of severe right heart failure.
METHODS: We reviewed the records of 41 patients who underwent tricuspid valve operation for severe tricuspid regurgitation caused by previously placed PPM or ICD leads.
RESULTS: During surgery, severe tricuspid regurgitation was found to be caused by the PPM or ICD leads in all 41 patients. There was a perforation of the tricuspid valve leaflet by the PPM or ICD lead in 7 patients, lead entanglement in the tricuspid valve occurred in 4 patients, lead impingement of the tricuspid valve leaflets occurred in 16 patients, and lead adherence to the tricuspid valve occurred in 14 patients. The septal leaflet was most often perforated (6 of 7). In the preoperative evaluation, valve malfunction due to the PPM or ICD lead was diagnosed preoperatively in only 5 of 41 (12%) patients by transthoracic echocardiography. All patients underwent successful tricuspid valve operation (22 tricuspid valve replacement), with one perioperative death occurring. During follow-up (range, 1 to 99 months), there was one patient who died from left-sided heart failure and three patients died of other causes. The remaining patients showed improvement in signs and symptoms of heart failure.
CONCLUSIONS: Damage to the tricuspid valve by PPM or ICD leads may result in severe symptomatic tricuspid regurgitation and may not be overtly visualized by echocardiography. This etiology should be considered when evaluating patients with severe right heart failure after PPM or ICD implantation.

Entities:  

Mesh:

Year:  2005        PMID: 15893186     DOI: 10.1016/j.jacc.2005.02.037

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  47 in total

1.  Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation.

Authors:  Gustavo Lopera; Gerald A Beathard; Jose Exaire; Roger Carrillo
Journal:  J Interv Card Electrophysiol       Date:  2012-06       Impact factor: 1.900

2.  Clinical significance of increased tricuspid valve incompetence following implantation of ventricular leads.

Authors:  Giselle A Baquero; Pradeep Yadav; Joshua B Skibba; Javier E Banchs; Latoya N Linton-Frazier; Eugene J Lengerich; Soraya M Samii; Erica Penny-Peterson; Deborah L Wolbrette; Jerry C Luck; Gerald V Naccarelli; Mario D Gonzalez
Journal:  J Interv Card Electrophysiol       Date:  2013-12       Impact factor: 1.900

3.  Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation.

Authors:  Katarzyna Wiechecka; Bartosz Wiechecki; Agnieszka Kapłon-Cieślicka; Agata Tymińska; Monika Budnik; Dominika Hołowaty; Krzysztof Jakubowski; Marcin Michalak; Elżbieta Świętoń; Przemysław Stolarz; Roman Steckiewicz; Marcin Grabowski; Piotr Scisło; Janusz Kochanowski; Krzysztof J Filipiak; Grzegorz Opolski
Journal:  Cardiol J       Date:  2019-06-21       Impact factor: 2.737

Review 4.  [ICD lead defects: diagnosis and therapeutical options].

Authors:  Christian G Wollmann; Dirk Böcker; Andreas Löher; Hans H Scheld; Günter Breithardt; Rainer Gradaus
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-02-11

Review 5.  Evaluation of tricuspid valve morphology and function by transthoracic three-dimensional echocardiography.

Authors:  Denisa Muraru; Luigi P Badano; Cristiano Sarais; Elena Soldà; Sabino Iliceto
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

6.  A Novel Defibrillation Tool: Percutaneously Delivered, Partially Insulated Epicardial Defibrillation.

Authors:  Ammar M Killu; Niyada Naksuk; Zdeněk Stárek; Christopher V DeSimone; Faisal F Syed; Prakriti Gaba; Jiří Wolf; Frantisek Lehar; Martin Pesl; Pavel Leinveber; Michal Crha; Dorothy Ladewig; Joanne Powers; Scott Suddendorf; David O Hodge; Gaurav Satam; Miroslav Novák; Tomas Kara; Charles J Bruce; Paul A Friedman; Samuel J Asirvatham
Journal:  JACC Clin Electrophysiol       Date:  2017-07

Review 7.  Tricuspid valve incompetence following implantation of ventricular leads.

Authors:  Giselle A Baquero; Jerry Luck; Gerald V Naccarelli; Mario D Gonzalez; Javier E Banchs
Journal:  Curr Heart Fail Rep       Date:  2015-04

8.  Single- and dual-site ventricular pacing entirely through the coronary sinus for patients with prior tricuspid valve surgery.

Authors:  Chin C Lee; Khuyen Do; Sati Patel; Steven K Carlson; Tomas Konecny; Philip M Chang; Rahul N Doshi
Journal:  J Interv Card Electrophysiol       Date:  2019-08-20       Impact factor: 1.900

9.  Reply: Tricuspid regurgitation severity associated with positioning of RV lead or other etiology assessed by intracardiac echocardiography.

Authors:  Anuj Mediratta; Karima Addetia; Roberto M Lang
Journal:  JACC Cardiovasc Imaging       Date:  2014-12

10.  Successful tricuspid valve replacement in a patient with severe pulmonary arterial hypertension and preserved right ventricular systolic function.

Authors:  Jamil A Aboulhosn; Ronald J Oudiz; Amish S Dave; Abbas Ardehali; David J Ross
Journal:  Case Rep Med       Date:  2009-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.